Alcohol consumption and associated factors among HIV/AIDS patients

Oliveira, Luiz Carlos Marques de; Anjos, Marcelo Guerra Tannús dos; Mustafé, Rafael Macedo; Borges, Aércio Sebastião

doi:10.1016/j.bjid.2016.01.010

Cited by 4 publications

(2 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several studies in LA have reported associations between SU and poor TA, and consequently TF [ 24 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 ]. In Brazil, 29.3% of PLWH reported not taking ART because of SU [ 94 ].…”

Section: Resultsmentioning

confidence: 99%

HIV and Substance Use in Latin America: A Scoping Review

Huff

Cárcamo

Diaz

et al. 2022

IJERPH

View full text Add to dashboard Cite

This scoping review aims to explore the interplay between substance use (SU) and HIV in Latin America (LA). Database searches yielded 3481 references; 196 were included. HIV prevalence among people who used substances (PWUS) ranged from 2.8–15.2%. SU definitions were variable throughout studies, and thus data were not easily comparable. In 2019, only 2% of new HIV infections were attributed to injection drug use (IDU) in LA. Factors associated with HIV among PWUS included being female, IDU and homelessness, and PWUS were likely to engage in risky sexual behaviors, start antiretroviral treatment late, have poor adherence, have treatment failure, be lost to follow-up, have comorbidities, and experience higher mortality rates and lower quality of life, as has been reported in PLWH with SU in other regions. Five intervention studies were identified, and only one was effective at reducing HIV incidence in PWUS. Interventions in other regions have varying success depending on context-specific characteristics, highlighting the need to conduct more research in the LA region. Though progress has been made in establishing SU as a major concern in people living with HIV (PLWH), much more is yet to be done to reduce the burden of HIV and SU in LA.

show abstract

Section: Resultsmentioning

confidence: 99%

HIV and Substance Use in Latin America: A Scoping Review

Huff

Cárcamo

Diaz

et al. 2022

IJERPH

View full text Add to dashboard Cite

show abstract

“…• by having a negative impact on HIV treatment, including alcohol-drug interactions, toxicity and/or reduction in treatment adherence and by increasing the risk of resistance to antiretroviral medications (Gross et al, 2017;de Oliveira et al, 2016;Rehm et al, 2010a);…”

Section: Box 14 Alcohol and Hiv/aidsmentioning

confidence: 99%

Hepatic Cannabinoid Signaling in the Regulation of Alcohol-Associated Liver Disease

Lees

Debenham

Squeglia

2021

ARCR

View full text Add to dashboard Cite

Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any speci c organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: "This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition".Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization.

show abstract

The prevalence of alcohol use disorders among people living with HIV/AIDS: a systematic review and meta-analysis

Duko

Ayalew

Ayano³

2019

Subst Abuse Treat Prev Policy

117

107

View full text Add to dashboard Cite

BackgroundAlcohol use disorder (AUD) is common among people living with HIV/AIDS (PLWHA) and associated with a greater risk of poor medication adherence, unsafe sexual behaviors as well as poor quality of life. To our knowledge, there is no previous systematic review and meta-analysis that reported the pooled prevalence estimate of AUD among PLWHA. Therefore, this review aimed to systematically review the available studies on the prevalence of AUD among PLWHA and forward possible recommendations for future clinical practice and research.MethodsPubMed, EMBASE, Psych INFO and SCOPUS databases were searched to identify the relevant studies. We have also scanned the reference lists of the eligible studies to supplement our electronic search. We used the Comprehensive Meta-Analysis software versions 3.0 to conduct a meta-analysis. Subgroup and sensitivity analysis were performed and Cochran’s Q- and the I2- test were employed to see the heterogeneity. The presence of publication bias was explored by utilizing Egger’s test and visual inspection of the symmetry in funnel plots.ResultsA total of 25 studies with 25,154 participants across developed and developing countries were included in the final analysis. Our meta-analysis revealed that the pooled prevalence estimate of AUD among PLWHA was found to be 29.80% (95% CI; 24.10–35.76). The prevalence of AUD was higher in males (26.90%) than female (13.37%) HIV patients. In this study, the pooled prevalence of AUD was considerably higher (31.52%) when measured by Alcohol Use Disorders Identification Test (AUDIT) as compared to Composite International Diagnostic Interview (CIDI) (13.51%). In addition, the pooled prevalence of AUD was higher in the developed countries (42.09%) while lower for developing countries (24.52%).ConclusionIn the current study, the pooled prevalence estimates of AUD among PLWHA was considerably high (29.80%). Screening and appropriate management of AUD among PLWHA are recommended.

show abstract

Alcohol consumption and associated factors among HIV/AIDS patients

Cited by 4 publications

References 4 publications

HIV and Substance Use in Latin America: A Scoping Review

HIV and Substance Use in Latin America: A Scoping Review

Hepatic Cannabinoid Signaling in the Regulation of Alcohol-Associated Liver Disease

The prevalence of alcohol use disorders among people living with HIV/AIDS: a systematic review and meta-analysis

Contact Info

Product

Resources

About